A universal multiplexing approach to unlock the hidden proteome
解锁隐藏蛋白质组的通用多重方法
基本信息
- 批准号:10478967
- 负责人:
- 金额:$ 33.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-15 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAmino AcidsBiologicalBiological ModelsBiologyCellsChemicalsCommunitiesComplexComputer AnalysisComputer softwareConsensusDataData AnalysesDatabasesDetectionEnzymesFractionationFutureGoalsHumanHuman BiologyLibrariesMass Spectrum AnalysisModernizationModificationOutcomePeptide HydrolasesPeptidesPerformancePhosphorylationPhosphorylation SitePost Translational Modification AnalysisPost-Translational Modification SitePreparationPropertyProtein RegionProteinsProteomeProteomicsProtocols documentationReportingReproducibilityResolutionSamplingSignal TransductionSiteTechnologyTestingTimeTrypsinWorkYeastsbasecombinatorialcomputerized toolsdata acquisitionexperimental studyhuman diseaseinnovationinstrumentmetaproteomicsmicrobiomenovelnovel strategiesphosphoproteomicstranscriptomics
项目摘要
SUMMARY
Mass spectrometry (MS) based proteomics has made remarkable advances over the past several years, now
enabling the detection of 8,000 proteins in a single analysis, or with extensive fractionation, protein detection
levels approaching that of transcriptomics can now be achieved. Despite such advances, a significant bias
exists in the proteome routinely detected by MS due to the near exclusive use of trypsin for proteolytic
cleavage during sample preparation. Trypsin is a wellsuited protease for proteomics, as it produces peptides
with favorable chemical composition for MS analysis, however, it also locks a considerable fraction of the
proteome in peptides either too small or too large for MS detection thus rendering these segments of the
proteome effectively invisible in >99% of the proteomics experiments performed to date. Only a handful of
global proteomics experiments have reported the use of alternative proteases, primarily due to the generally
superior performance of trypsin, and the increased instrument time required to analyze additional samples a
limiting factor for most labs. Recently developed MS approaches, specifically dataindependent acquisition
(DIA), operate under new experimental and computational paradigms which rely on deconvolution of highly
complex MS spectra and matching to peptide or spectral databases for detection. This new paradigm presents
the opportunity to multiplex proteomic samples generated from a variety of different proteases in a single MS
analysis. However, to date DIA analysis has been exclusively developed for tryptic peptides. Here we propose
an innovative DIA acquisition and computational analysis approach to multiplex multiple proteases and unlock
the hidden proteome. To achieve the goals of this proposal we will first optimize DIA for nontrypsin proteases,
and then apply these optimized conditions in a DIA multiplexed setting with a mixture of different proteases.
Lastly, we will further develop and apply this framework to the analysis of posttranslational modifications (e.g.
phosphorylation) where increased proteome coverage is essential for modification detection and localization.
Successful completion of this work will provide a robust framework to dramatically increase the proteome
routinely detected and quantified in MS analysis. Importantly, all details of this workflow, from sample handling
to software for data analysis, will be well documented in stepbystep online protocols and freely distributed to
the community to enable rapid integration of this approach into modern proteomics workflows.
概括
基于质谱(MS)的蛋白质组学在过去几年中取得了显着进步,现在
在单个分析中或以广泛的分馏,启用8,000蛋白的检测,蛋白质检测
现在可以达到接近转录组学的水平。尽管有这样的进步,但很大的偏见
由于近乎独家使用胰蛋白酶对蛋白水解,MS常规检测到的蛋白质组存在于蛋白质组中
样品制备过程中的裂解。胰蛋白酶是蛋白质组学的能蛋白酶,因为它会产生肽
但是,具有有利的化学成分用于MS分析,它还锁定了一定数的考虑
Petides中的蛋白质组太小或太大而无法检测到MS检测
迄今为止,蛋白质组学实验的> 99%的蛋白质组有效地看不见。只有少数
全球蛋白质组学实验报告了替代蛋白酶的使用,主要是由于通常是由于
胰蛋白酶的出色性能以及分析其他样品所需的仪器时间增加
大多数实验室的限制因素。最近开发的MS方法,特别是数据依赖性收购
(DIA),在新的实验和计算范式下运行,这些范式依赖于高度的反卷积
复杂的MS光谱并与肽或光谱数据库匹配以进行检测。这个新的范式礼物
单个MS中各种不同蛋白酶产生的多种蛋白质组学样品的机会
分析。但是,迄今为止,DIA分析是针对胰蛋白酶Petides开发的。我们在这里提出
一种创新的DIA获取和计算分析方法,用于多种多种蛋白酶并解锁
隐藏的protectome。为了实现该建议的目标,我们将首先优化非tryprypsin蛋白的DIA,
然后将这些优化的条件在DIA多路复用的设置中使用不同的蛋白酶的混合物。
最后,我们将进一步开发并将此框架应用于翻译后修饰的分析(例如,
磷酸化)其中增加蛋白质组覆盖范围对于修饰检测和定位至关重要。
成功完成这项工作将提供一个强大的框架,以显着增加蛋白质组
在MS分析中常规检测和量化。重要的是,该工作流程的所有细节,都可以从样本处理
对于数据分析的软件,将在StepbyStep在线协议中得到充分记录,并自由分发到
社区能够将这种方法快速整合到现代蛋白质组学工作流程中。
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Recurrent Co-Option and Recombination of Cytokine and Three Finger Proteins in Multiple Reproductive Tissues Throughout Salamander Evolution.
- DOI:10.3389/fcell.2022.828947
- 发表时间:2022
- 期刊:
- 影响因子:5.5
- 作者:Wilburn DB;Kunkel CL;Feldhoff RC;Feldhoff PW;Searle BC
- 通讯作者:Searle BC
Optimizing Linear Ion-Trap Data-Independent Acquisition toward Single-Cell Proteomics.
- DOI:10.1021/acs.analchem.3c00842
- 发表时间:2023-06
- 期刊:
- 影响因子:7.4
- 作者:Teeradon Phlairaharn;Zilu Ye;Elena Krismer;A. Pedersen;M. Pietzner;J. Olsen;E. Schoof;B. Searle
- 通讯作者:Teeradon Phlairaharn;Zilu Ye;Elena Krismer;A. Pedersen;M. Pietzner;J. Olsen;E. Schoof;B. Searle
CIDer: A Statistical Framework for Interpreting Differences in CID and HCD Fragmentation.
- DOI:10.1021/acs.jproteome.0c00964
- 发表时间:2021-04-02
- 期刊:
- 影响因子:4.4
- 作者:Wilburn DB;Richards AL;Swaney DL;Searle BC
- 通讯作者:Searle BC
A Multipathway Phosphopeptide Standard for Rapid Phosphoproteomics Assay Development.
- DOI:10.1016/j.mcpro.2023.100639
- 发表时间:2023-10
- 期刊:
- 影响因子:7
- 作者:Searle, Brian C.;Chien, Allis;Koller, Antonius;Hawke, David;Herren, Anthony W.;Kim, Jenny Kim;Lee, Kimberly A.;Leib, Ryan D.;Nelson, Alissa J.;Patel, Purvi;Ren, Jian Min;Stemmer, Paul M.;Zhu, Yiying;Neely, Benjamin A.;Patel, Bhavin
- 通讯作者:Patel, Bhavin
Data-Independent Acquisition Protease-Multiplexing Enables Increased Proteome Sequence Coverage Across Multiple Fragmentation Modes.
- DOI:10.1021/acs.jproteome.1c00960
- 发表时间:2022-04-01
- 期刊:
- 影响因子:4.4
- 作者:Richards, Alicia L.;Chen, Kuei-Ho;Wilburn, Damien B.;Stevenson, Erica;Polacco, Benjamin J.;Searle, Brian C.;Swaney, Danielle L.
- 通讯作者:Swaney, Danielle L.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Danielle L Swaney其他文献
Danielle L Swaney的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Danielle L Swaney', 18)}}的其他基金
A universal multiplexing approach to unlock the hidden proteome
解锁隐藏蛋白质组的通用多重方法
- 批准号:
10240468 - 财政年份:2019
- 资助金额:
$ 33.08万 - 项目类别:
相似国自然基金
低蛋白日粮脂肪和蛋白质互作影响氨基酸消化率的机制
- 批准号:32302793
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
关键非催化氨基酸残基影响新型GH43家族双功能酶底物特异性的机制研究
- 批准号:32301052
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
影响植物磷砷选择性吸收关键氨基酸位点的挖掘及分子机制研究
- 批准号:42307009
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
孕期母体支链氨基酸代谢紊乱和子代支链氨基酸代谢酶基因遗传变异联合作用对儿童神经行为发育影响的队列研究
- 批准号:82373581
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
RET基因634位点不同氨基酸改变对甲状腺C细胞的影响与机制研究
- 批准号:82370790
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
相似海外基金
Designing novel therapeutics for Alzheimer’s disease using structural studies of tau
利用 tau 蛋白结构研究设计治疗阿尔茨海默病的新疗法
- 批准号:
10678341 - 财政年份:2023
- 资助金额:
$ 33.08万 - 项目类别:
Preclinical Development of a Novel Therapeutic Agent for Idiopathic Pulmonary Fibrosis
特发性肺纤维化新型治疗剂的临床前开发
- 批准号:
10696538 - 财政年份:2023
- 资助金额:
$ 33.08万 - 项目类别:
Development and Production of Standardized Reference Diets for Zebrafish Research
斑马鱼研究标准化参考饲料的开发和生产
- 批准号:
10823702 - 财政年份:2023
- 资助金额:
$ 33.08万 - 项目类别:
Stabilizing the tripartite synaptic complex following TBI
TBI 后稳定三方突触复合体
- 批准号:
10844877 - 财政年份:2023
- 资助金额:
$ 33.08万 - 项目类别:
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
- 批准号:
10761044 - 财政年份:2023
- 资助金额:
$ 33.08万 - 项目类别: